Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael J Grayling

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Pharmaceutical Statistics|November 27, 2015
Do single-arm trials have a role in drug development plans incorporating randomised trials?Michael J Grayling, Adrian P Mander
JCO Precision Oncology|December 24, 2021
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported AdequatelyMichael J Grayling, Adrian P Mander
Journal of Biopharmaceutical Statistics|February 23, 2022
Optimised point estimators for multi-stage single-arm phase II oncology trialsMichael J Grayling, Adrian P Mander
The Stata Journal|December 9, 2024
Calculations involving the multivariate normal and multivariate t distributions with and without truncationMichael J Grayling, Adrian P Mander
Contemporary Clinical Trials|June 3, 2021
Accounting for variation in the required sample size in the design of group-sequential trialsMichael J Grayling, Adrian P Mander
BMC Cancer|February 2, 2020
A web application for the design of multi-arm clinical trialsMichael J Grayling, James Ms Wason
BMC Medical Research Methodology|January 30, 2019
Re-formulating Gehan's design as a flexible two-stage single-arm trialMichael J Grayling, Adrian P Mander
Statistical Methods in Medical Research|November 17, 2022
Point estimation following a two-stage group sequential trialMichael J Grayling, James Ms Wason
Journal of Biopharmaceutical Statistics|January 25, 2022
A stochastically curtailed single-arm phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pharmaceutical Statistics|August 30, 2020
A stochastically curtailed two-arm randomised phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Pharmaceutical Statistics|November 27, 2015
Do single-arm trials have a role in drug development plans incorporating randomised trials?Michael J Grayling, Adrian P Mander
JCO Precision Oncology|December 24, 2021
Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported AdequatelyMichael J Grayling, Adrian P Mander
Journal of Biopharmaceutical Statistics|February 23, 2022
Optimised point estimators for multi-stage single-arm phase II oncology trialsMichael J Grayling, Adrian P Mander
The Stata Journal|December 9, 2024
Calculations involving the multivariate normal and multivariate t distributions with and without truncationMichael J Grayling, Adrian P Mander
Contemporary Clinical Trials|June 3, 2021
Accounting for variation in the required sample size in the design of group-sequential trialsMichael J Grayling, Adrian P Mander
BMC Cancer|February 2, 2020
A web application for the design of multi-arm clinical trialsMichael J Grayling, James Ms Wason
BMC Medical Research Methodology|January 30, 2019
Re-formulating Gehan's design as a flexible two-stage single-arm trialMichael J Grayling, Adrian P Mander
Statistical Methods in Medical Research|November 17, 2022
Point estimation following a two-stage group sequential trialMichael J Grayling, James Ms Wason
Journal of Biopharmaceutical Statistics|January 25, 2022
A stochastically curtailed single-arm phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pharmaceutical Statistics|August 30, 2020
A stochastically curtailed two-arm randomised phase II trial design for binary outcomesMartin Law, Michael J Grayling, Adrian P Mander
Pageof 5